DNLI
Denali Therapeutics Inc.
Latest News for DNLI
Denali Therapeutics ( ($DNLI) ) has shared an update. On December 9, 2025, Denali Therapeutics entered into an underwriting agreement with major fi......
Stifel Nicolaus analyst Paul Matteis reiterated a Buy rating on Denali Therapeutics today and set a price target of $37.00. Matteis covers the Heal......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Arrowhead Pharmaceuticals (ARWR – Research Report)......
H.C. Wainwright analyst Andrew Fein maintained a Buy rating on Denali Therapeutics yesterday and set a price target of $32.00. The company’s shares......
In a report released yesterday, Mayank Mamtani from B. Riley Securities maintained a Buy rating on Denali Therapeutics, with a price target of $30.......
In a report released yesterday, Tazeen Ahmad from Bank of America Securities reiterated a Buy rating on Denali Therapeutics, with a price target of......
News data is sourced from MarketXLS API and updated regularly.
Showing 6 of 6 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DNLI | $17.98 | +3.5% | 1.40M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Denali Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW